The Impact of Inflammatory Markers and Obesity in Chronic Venous Disease

被引:2
作者
Petrascu, Flavia-Medana [1 ,2 ]
Matei, Sergiu-Ciprian [3 ,4 ]
Margan, Madalin-Marius [5 ,6 ]
Ungureanu, Ana-Maria [7 ]
Olteanu, Gheorghe-Emilian [1 ,8 ,9 ]
Murariu, Marius-Sorin [3 ,4 ]
Olariu, Sorin [3 ,4 ]
Marian, Catalin [1 ,2 ,10 ]
机构
[1] Victor Babes Univ Med, Dept Doctoral Studies & Pharm, Timisoara 300041, Romania
[2] Victor Babes Univ Med & Pharm, Dept Biochem, Timisoara 300041, Romania
[3] Victor Babes Univ Med & Pharm, Abdominal Surg & Phlebol Res Ctr, Timisoara 300041, Romania
[4] Pius Brinzeu Emergency Cty Hosp, Surg Dept 1, Timisoara 300723, Romania
[5] Victor Babes Univ Med & Pharm, Dept Funct Sci, Discipline Publ Hlth, Timisoara 300041, Romania
[6] Victor Babes Univ Med & Pharm, Fac Med, Ctr Translat Res & Syst Med, Timisoara 300041, Romania
[7] Victor Babes Univ Med & Pharm, Dept Radiol & Med Imaging, Timisoara 300041, Romania
[8] Victor Babes Univ Med & Pharm, Fac Pharm, Res Ctr Pharmaco Toxicol Evaluat, Timisoara 300041, Romania
[9] Victor Babes Univ Med & Pharm, Ctr Res & Innovat Personalized Med Resp Dis, Timisoara 300041, Romania
[10] Victor Babes Univ Med & Pharm, Ctr Complex Networks Sci, Timisoara 300041, Romania
关键词
obesity; inflammation; chronic venous disease; endothelial dysfunction; microcirculatory damage; C-REACTIVE PROTEIN; INSUFFICIENCY; MANAGEMENT; COMPRESSION; DISORDERS;
D O I
10.3390/biomedicines12112524
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Chronic venous disease (CVD) represents a significant health challenge, particularly in obese individuals. This study focuses on the interplay between inflammation, obesity, and CVD, by analyzing the role of inflammatory markers in the disease progression. Methods: Clinical and paraclinical data of 619 patients hospitalized and treated in the Phlebology Department (1stSurgical Department, "Pius Br & icirc;nzeu" Emergency County Hospital Timisoara, Romania) between 2018 and 2024 were analyzed. Results: The statistical analysis revealed that age, C-reactive protein (CRP), fibrinogen, and absolute neutrophil count (ANC) were key predictors of CVD progression. Specifically, elevated CRP and fibrinogen levels correlated strongly with increased CVD severity, particularly in patients with higher body-mass index (BMI). BMI, while not an independent predictor, contributed indirectly to the disease severity through its association with these inflammatory markers. The logistic regression model incorporating age, BMI, CRP, fibrinogen, and ANC demonstrated a high predictive accuracy, with an area under the curve (AUC) of 0.902, highlighting the models reliability in stratifying patients at risk for severe CVD. Conclusions: This predictive model not only aids in identifying high-risk patients but also reinforces inflammation as a critical therapeutic target in CVD management.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] Impact of statin treatment on patients diagnosed with chronic venous disease. Morphological analysis of the venous wall and clinical implications
    Matei, Sergiu-Ciprian
    Matei, Mervat
    Anghel, Flavia Medana
    Derban, Mihnea Dragos
    Olariu, Andra
    Olariu, Sorin
    PHLEBOLOGY, 2022, 37 (03) : 188 - 195
  • [32] Involvement of inflammatory markers in pathogenesis of venous thromboembolism
    Cocoi, Alexandra Florina
    Pop, Dana
    Cocoi, Mihai
    Serban, Adela Mihaela
    Vida-Simiti, Luminita Animarie
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2017, 25 (03): : 227 - 236
  • [33] Inflammatory plasma markers and risk for venous thromboembolism
    Sveinsdottir, Signy V.
    Svensson, Peter J.
    Engstrom, Gunnar
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2014, 38 (02) : 190 - 195
  • [34] Systematic review of anaemia and inflammatory markers in chronic obstructive pulmonary disease
    de Carvalho Hoepers, Andrea Thives
    Menezes, Marcia Margarete
    Froede, Tania Silvia
    CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2015, 42 (03) : 231 - 239
  • [35] Mononuclear Leukocyte Apoptosis and Inflammatory Markers in Patients with Chronic Kidney Disease
    Dounousi, Evangelia
    Koliousi, Elli
    Papagianni, Aikaterini
    Ioannou, Kyriakos
    Zikou, Xanthi
    Katopodis, Konstantinos
    Kelesidis, Apostolos
    Tsakiris, Dimitrios
    Siamopoulos, Kostas C.
    AMERICAN JOURNAL OF NEPHROLOGY, 2012, 36 (06) : 531 - 536
  • [36] Impact of obesity on disease activity and disease outcome in inflammatory bowel disease: Results from the Swiss inflammatory bowel disease cohort
    Greuter, Thomas
    Porchet, Frederic
    Braga-Neto, Manuel B.
    Rossel, Jean-Benoit
    Biedermann, Luc
    Schreiner, Philipp
    Scharl, Michael
    Schoepfer, Alain M.
    Safroneeva, Ekaterina
    Straumann, Alex
    Rogler, Gerhard
    Vavricka, Stephan R.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2020, 8 (10) : 1196 - 1207
  • [37] Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
    Rohm, Ilonka
    Kretzschmar, Daniel
    Pistulli, Rudin
    Franz, Marcus
    Schulze, P. Christian
    Stumpf, Christian
    Yilmaz, Atilla
    JOURNAL OF IMMUNOLOGY RESEARCH, 2016, 2016
  • [38] Impact of Obesity on the Course of Management of Inflammatory Bowel Disease-A Review
    Michalak, Agata
    Kasztelan-Szczerbinska, Beata
    Cichoz-Lach, Halina
    NUTRIENTS, 2022, 14 (19)
  • [39] The relationship between inflammatory markers, angiogenesis, and obesity
    Tahergorabi, Zoya
    Khazaei, Majid
    ARYA ATHEROSCLEROSIS, 2013, 9 (04) : 247 - 253
  • [40] Asthma and obesity increase inflammatory markers in children
    Shailesh, Harshita
    Noor, Safa
    Hayati, Lena
    Belavendra, Antonisamy
    Van Panhuys, Nicholas
    Abou-Samra, Abdul Badi
    Worgall, Stefan
    Janahi, Ibrahim
    FRONTIERS IN ALLERGY, 2025, 5